{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:55:29Z","timestamp":1792796129542,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.amjmed.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T10:43:18Z","timestamp":1642848198000},"page":"S20-S23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S1","title":["Evaluation and Management Strategies for GI Involvement with Amyloidosis"],"prefix":"10.1016","volume":"135","author":[{"given":"Cassandra D.L.","family":"Fritz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjmed.2022.01.008_bib0001","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjmed.2022.01.008_bib0002","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrgastro.2009.147","article-title":"Systemic amyloidosis and the gastrointestinal tract","volume":"6","author":"Sattianayagam","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.01.008_bib0003","doi-asserted-by":"crossref","first-page":"e13229","DOI":"10.1111\/nmo.13229","article-title":"Clinical implications of gastrointestinal symptoms in systemic amyloidosis","volume":"30","author":"Yen","year":"2018","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.008_bib0004","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12875-020-01252-4","article-title":"Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner","volume":"21","author":"Gertz","year":"2020","journal-title":"BMC Fam Pract"},{"issue":"5","key":"10.1016\/j.amjmed.2022.01.008_bib0005","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MEG.0000000000002030","article-title":"Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations","volume":"33","author":"Nakov","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.01.008_bib0006","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00428-016-1916-y","article-title":"Amyloid in biopsies of the gastrointestinal tract-a retrospective observational study on 542 patients","volume":"468","author":"Freudenthaler","year":"2016","journal-title":"Virchows Arch"},{"issue":"12","key":"10.1016\/j.amjmed.2022.01.008_bib0007","doi-asserted-by":"crossref","first-page":"e13469","DOI":"10.1111\/nmo.13469","article-title":"Intestinal involvement in amyloidosis is a sequential process","volume":"30","author":"den Braber-Ymker","year":"2018","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"10.1016\/j.amjmed.2022.01.008_bib0008","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/BF01296621","article-title":"Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis","volume":"36","author":"Matsumoto","year":"1991","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.amjmed.2022.01.008_bib0009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/00365529208999949","article-title":"Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy","volume":"27","author":"Suhr","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.amjmed.2022.01.008_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1750-1172-9-61","article-title":"THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease","volume":"9","author":"Wixner","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2022.01.008_bib0011","doi-asserted-by":"crossref","first-page":"e00206","DOI":"10.14309\/ctg.0000000000000206","article-title":"Comparing clinical, imaging, and physiological correlates of intestinal pseudo-obstruction: systemic sclerosis vs amyloidosis and paraneoplastic syndrome","volume":"11","author":"Pamarthy","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.01.008_bib0012","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/s10165-012-0675-0","article-title":"Successful treatment of protein-losing enteropathy due to AA amyloidosis with octreotide in a patient with rheumatoid arthritis","volume":"23","author":"Shin","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.amjmed.2022.01.008_bib0013","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jgh.13996","article-title":"Systemic amyloidosis with gastrointestinal involvement: diagnosis from endoscopic and histological views","volume":"33","author":"Iida","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.008_bib0014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0016-5107(94)70008-7","article-title":"Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein","volume":"40","author":"Tada","year":"1994","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.amjmed.2022.01.008_bib0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cgh.2007.02.038","article-title":"Clinical recognition of Al type amyloidosis of the luminal gastrointestinal tract","volume":"5","author":"James","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.008_bib0016","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/17474124.2018.1397511","article-title":"Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years","volume":"12","author":"Wixner","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.008_bib0017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2012.373","article-title":"Clinical guideline: management of gastroparesis","volume":"108","author":"Camilleri","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.amjmed.2022.01.008_bib0018","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2982.2012.01991.x","article-title":"Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy","volume":"24","author":"Wixner","year":"2012","journal-title":"Neurogastroenterol Motil"},{"issue":"9","key":"10.1016\/j.amjmed.2022.01.008_bib0019","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF01391374","article-title":"Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency","volume":"27","author":"Read","year":"1982","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.amjmed.2022.01.008_bib0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-115-7-577_1","article-title":"Octreotide for diarrhea in amyloidosis","volume":"115","author":"Yam","year":"1991","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.amjmed.2022.01.008_bib0021","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/jnnp.55.9.860-a","article-title":"Octreotide\u2013a new treatment for diarrhoea in familial amyloidotic polyneuropathy","volume":"55","author":"Carvalho","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"855","key":"10.1016\/j.amjmed.2022.01.008_bib0022","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/pgmj.73.855.62-b","article-title":"Octreotide therapy for diarrhoea","volume":"73","author":"Gilanders","year":"1997","journal-title":"Postgrad Med J"},{"issue":"8","key":"10.1016\/j.amjmed.2022.01.008_bib0023","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/gut.35.8.1064","article-title":"Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders","volume":"35","author":"Haruma","year":"1994","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.008_bib0024","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/13506120500032725","article-title":"Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide","volume":"12","author":"Fushimi","year":"2005","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.amjmed.2022.01.008_bib0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5694\/mja18.00241","article-title":"Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management","volume":"209","author":"Black","year":"2018","journal-title":"Med J Aust"},{"issue":"7","key":"10.1016\/j.amjmed.2022.01.008_bib0026","article-title":"Lactulose versus polyethylene glycol for chronic constipation","author":"Lee-Robichaud","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.amjmed.2022.01.008_bib0027","first-page":"500","article-title":"Management of constipation in older adults","volume":"92","author":"Mounsey","year":"2015","journal-title":"Am Fam Physician"},{"issue":"11","key":"10.1016\/j.amjmed.2022.01.008_bib0028","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","article-title":"Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia","volume":"10","author":"Tack","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.01.008_bib0029","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MOG.0000000000000393","article-title":"Functional dyspepsia and gastroparesis","volume":"33","author":"Tack","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.01.008_bib0030","doi-asserted-by":"crossref","first-page":"e42747","DOI":"10.5812\/aapm.42747","article-title":"Pharmacological approach for managing pain in irritable bowel syndrome: a review article","volume":"7","author":"Chen","year":"2017","journal-title":"Anesth Pain Med"},{"issue":"6","key":"10.1016\/j.amjmed.2022.01.008_bib0031","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MCG.0b013e3182a88357","article-title":"Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"48","author":"Khanna","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.01.008_bib0032","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ajcn\/83.2.350","article-title":"Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1","volume":"83","author":"Caccialanza","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"10.1016\/j.amjmed.2022.01.008_bib0033","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/0148607113501328","article-title":"Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatment","volume":"38","author":"Caccialanza","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.008_bib0034","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3324\/haematol.2012.070359","article-title":"A prospective study of nutritional status in immunoglobulin light chain amyloidosis","volume":"98","author":"Sattianayagam","year":"2013","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.amjmed.2022.01.008_bib0035","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.nut.2015.04.011","article-title":"Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis","volume":"31","author":"Caccialanza","year":"2015","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.amjmed.2022.01.008_bib0036","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2165\/00003495-198020030-00005","article-title":"Clinical use of medium chain triglycerides","volume":"20","author":"Ruppin","year":"1980","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.amjmed.2022.01.008_bib0037","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000506617","article-title":"When to suspect a diagnosis of amyloidosis","volume":"143","author":"Vaxman","year":"2020","journal-title":"Acta Haematol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:26:00Z","timestamp":1757582760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":37,"alternative-id":["S0002934322000304"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.01.008","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and Management Strategies for GI Involvement with Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}